All Pathways
Colorectal SurgeryEmergency

Anorectal Abscess and Perianal Sepsis (ASCRS 2022)

Anorectal Abscess and Perianal Sepsis (ASCRS 2022): Suspected anorectal abscess (adult) → Clinical assessment → Signs of necrotising infection (Fournier...

Pathway Overview

17 steps

Algorithm Steps

17 total

  1. 01Start

    Suspected anorectal abscess (adult)

    Perianal or rectal pain, swelling, fever. Children: seek paediatric surgical advice.

  2. 02Action

    Clinical assessment

    History, perineal examination and digital rectal examination

    • Pain, swelling, fever; prior abscess, fistula or anorectal surgery
    • Risk factors: diabetes, immunosuppression, neutropenia, HIV, Crohn's disease
    • Look for fluctuance, cellulitis, an external fistula opening, necrosis or crepitus
    • Check glucose, HbA1c and urine ketones (undiagnosed diabetes). High glucose or ketones: treat (DKA pathway if present); do not delay drainage
    • Signs of sepsis: FBC, creatinine, CRP, lactate and blood cultures
    • Differentials: thrombosed haemorrhoid, fissure, pilonidal disease, hidradenitis, cancer, STI
  3. 03Decision

    Signs of necrotising infection (Fournier's gangrene)?

    Yes if any: crepitus, dusky or necrotic skin, rapidly spreading cellulitis, pain out of proportion, or severe sepsis

    • Rapidly spreading cellulitis
    • Crepitus on examination
    • Dusky or necrotic skin
    • Pain out of proportion to signs
    • Severe sepsis or septic shock
  4. If Yes
    1. 04Warning

      Yes: suspected Fournier's gangrene or severe sepsis - emergency surgery now

      Life-threatening. Resuscitate, call the senior surgeon and ICU. Theatre for debridement or urgent drainage. Imaging must not delay surgery.

      • Theatre for debridement of all necrotic tissue as soon as possible
      • Adult IV antibiotics now (CrCl >50 mL/min): meropenem 1 g 8-hourly PLUS vancomycin PLUS clindamycin 600 mg 8-hourly
      • Vancomycin: load 25-30 mg/kg IV (max 2.5 g), then 15-20 mg/kg (max 2 g) 12-hourly; actual body weight; reduce frequency in renal impairment
    2. 05Action

      Fournier's: after the first debridement

      Serial surgery and targeted antibiotics

      • Send tissue for culture at the first operation
      • Plan repeat debridement until no necrotic tissue remains
      • De-escalate antibiotics by culture results and clinical response
      • Multidisciplinary team (colorectal, urology, plastics, ICU); faecal diversion only if faecal soiling or sphincter damage makes it necessary
    3. 06End

      Fournier's: continue ICU and surgical care

      Specialist inpatient care

    If No
    1. 07Action

      No necrotising signs: classify abscess site

      The site decides the drainage route

      • Perianal: superficial, next to the anal verge (most common)
      • Ischiorectal: deeper, lateral buttock swelling
      • Intersphincteric: rectal pain, little to see outside; felt on rectal examination
      • Supralevator or high ischiorectal: pain may refer to perineum, lower back or buttocks; examination may look normal
      • Horseshoe: crosses the midline through the deep postanal space
    2. 08Warning

      Before drainage: check high-risk groups

      Neutropenia or other immunosuppression, Crohn's disease, high endocarditis risk (prosthetic valve, previous endocarditis, rheumatic heart disease). High glucose or ketones: treat (DKA pathway if present); do not delay drainage. Children: paediatric surgical advice.

      • Neutropenia: IV antibiotics within 1 hour by the neutropenic fever protocol (adult, no penicillin allergy: piperacillin-tazobactam 4.5 g IV 6-hourly); haematology advice. Fluctuance: drain. No fluctuance: antibiotics first and early imaging.
      • Crohn's disease: MRI; drain and place a loose seton; no fistulotomy unless a simple low fistula without proctitis; involve the IBD team
      • High endocarditis risk (prosthetic valve, previous endocarditis, rheumatic heart disease, some congenital heart disease, heart transplant with valve disease): antibiotics before drainage
    3. 09Decision

      Simple superficial perianal abscess?

      Yes: superficial, next to the anal verge, first episode, not immunosuppressed, no Crohn's disease; no imaging. No: occult, deep, recurrent, horseshoe, immunosuppressed or Crohn's disease; image (MRI preferred) if it will not delay drainage.

      • Simple perianal abscess: no imaging
      • Occult or deep abscess, recurrence, complex fistula: MRI preferred
      • CT if MRI is not available quickly or a pelvic source is suspected
      • Endoanal ultrasound where local skill exists
    4. If Yes
      1. 10Action

        Yes: superficial perianal abscess - incision and drainage

        Drain promptly. This is the main treatment. Sepsis: IV antibiotics within 60 minutes; do not delay drainage.

        • Incision close to the anal verge, large enough to drain; protect the sphincter
        • Break up loculations
        • No routine packing: less pain, same healing and recurrence
        • Leave the wound open; no primary closure
        • Fit, immunocompetent, small abscess, no sepsis: day-case or bedside drainage under local anaesthetic is possible
        • Option: drainage catheter (for example Pezzer or Malecot)
      2. 11Decision

        Cellulitis, systemic infection or immunosuppression?

        Antibiotics are not routine after drainage. Give them only for these indications.

      3. If Yes
        1. 12Action

          Yes: antibiotics with drainage

          Drainage is still the main treatment

          • Indications: cellulitis, systemic signs of infection, or immunosuppression (for example neutropenia, HIV, immunosuppressive drugs)
          • Choice and dose: eTG or local guideline; cover skin and bowel flora. Neutropenia: neutropenic fever protocol
          • MRSA risk or MRSA isolated with sepsis, raised or low white cell count: add anti-MRSA cover
          • Send pus for culture if immunosuppressed, recurrent, non-healing or at risk of multidrug-resistant organisms
        2. 13Action

          Assess for fistula

          30-70% have a fistula at presentation

          • No obvious fistula: do not probe to look for one (false tract risk)
          • Obvious low fistula with no or minimal sphincter involvement: fistulotomy may be done in selected patients
          • Fistula through sphincter muscle: loose draining seton; definitive repair later
          • No primary fistulotomy if complex, horseshoe, Crohn's disease, poor continence or prior anorectal surgery
          • Goodsall's rule: reliable for anterior openings, less reliable for posterior
        3. 14Action

          Post-drainage care

          Wound care and follow-up

          • Leave the wound open; no packing
          • Warm water baths or shower rinses for comfort and hygiene
          • Regular analgesia; fibre and stool softeners
          • Culture pus if the wound does not heal or the abscess recurs
          • Surgical follow-up; return early if fever, spreading redness, worse pain or urinary retention
          • Persistent discharge or recurrence: assess for fistula (MRI or examination under anaesthesia)
        4. 15Outcome

          Outcomes

          Recurrence and fistula

          • Recurrence up to 44%, most within 1 year
          • Risk factors: inadequate drainage, loculations, horseshoe abscess, no primary fistulotomy
          • Persistent fistula: refer for definitive fistula treatment
        If No
        1. 16Action

          No: no antibiotics after drainage

          Uncomplicated abscess in a healthy patient: antibiotics do not improve healing or reduce recurrence

          • Adequate drainage is the treatment
          • Reassess if cellulitis spreads or fever persists
        2. Path rejoins step 13Shared downstream outcome
      If No
      1. 17Action

        No: deep or complex abscess - drain in theatre

        Examination under anaesthesia. Sepsis: IV antibiotics within 60 minutes, then drain urgently; do not wait for imaging. Image first only if it will not delay drainage. The drainage route depends on the abscess origin.

        • Intersphincteric: drain into the anal canal (internal sphincterotomy) or through the intersphincteric groove
        • Supralevator from an intersphincteric abscess: drain through the rectal wall
        • Supralevator from an ischiorectal abscess: drain through the perianal skin
        • Supralevator from pelvic disease (diverticulitis, Crohn's disease): CT and treat the source; do not drain through the perineum
        • Horseshoe: modified Hanley (open deep postanal space, counter-incisions, seton); no primary lay-open fistulotomy
        • Wrong drainage route can create a complex fistula
      2. Path rejoins step 11Shared downstream outcome

Guideline Source

ASCRS Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula (Gaertner WB et al., Dis Colon Rectum 2022;65:964-985)

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Adults only. Children and infants need paediatric surgical advice.
  • Fistula repair (seton, LIFT, flap) and Crohn's disease long-term care are covered only briefly.
  • Fournier's gangrene: first steps only; antibiotic doses from Australian eTG-based regimen (Safer Care Victoria 2025) for normal renal function.
  • Antibiotic choice for uncomplicated cellulitis follows local guidance (eTG).

Contraindicated Populations

Children and infants (paediatric surgical advice)Neutropenia or other immunosuppression (modified approach: antibiotics, early imaging)Crohn's disease (loose seton; avoid fistulotomy unless simple low fistula without proctitis)

Applicable Regions

AUUSEUUK

AU: Fournier's antibiotics follow Safer Care Victoria 2025 (adapted from eTG Antibiotic v16): meropenem 1 g IV 8-hourly plus vancomycin plus clindamycin 600 mg IV 8-hourly. Neutrophils are reported as x10^9/L (ANC 1.0 x10^9/L = 1000/mm3).

US: IDSA 2014 empiric necrotising infection regimens include vancomycin or linezolid plus piperacillin-tazobactam, a carbapenem, or ceftriaxone plus metronidazole.

Version 2Next review: 2027-09-30

Frequently Asked Questions

What is the Anorectal Abscess and Perianal Sepsis (ASCRS 2022)?

The Anorectal Abscess and Perianal Sepsis (ASCRS 2022) is a emergency clinical algorithm for Colorectal Surgery. It provides a structured decision tree to guide clinical decision-making, based on ASCRS Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula (Gaertner WB et al., Dis Colon Rectum 2022;65:964-985).

What guideline is the Anorectal Abscess and Perianal Sepsis (ASCRS 2022) based on?

This algorithm is based on ASCRS Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula (Gaertner WB et al., Dis Colon Rectum 2022;65:964-985) (DOI: 10.1097/DCR.0000000000002473).

What are the limitations of the Anorectal Abscess and Perianal Sepsis (ASCRS 2022)?

Known limitations include: Adults only. Children and infants need paediatric surgical advice.; Fistula repair (seton, LIFT, flap) and Crohn's disease long-term care are covered only briefly.; Fournier's gangrene: first steps only; antibiotic doses from Australian eTG-based regimen (Safer Care Victoria 2025) for normal renal function.; Antibiotic choice for uncomplicated cellulitis follows local guidance (eTG).. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Anorectal Abscess and Perianal Sepsis (ASCRS 2022) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free